1. Home
  2. AQST vs FOA Comparison

AQST vs FOA Comparison

Compare AQST & FOA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AQST
  • FOA
  • Stock Information
  • Founded
  • AQST 2004
  • FOA 2013
  • Country
  • AQST United States
  • FOA United States
  • Employees
  • AQST N/A
  • FOA N/A
  • Industry
  • AQST Biotechnology: Pharmaceutical Preparations
  • FOA Finance Companies
  • Sector
  • AQST Health Care
  • FOA Finance
  • Exchange
  • AQST Nasdaq
  • FOA Nasdaq
  • Market Cap
  • AQST 272.9M
  • FOA 248.8M
  • IPO Year
  • AQST 2018
  • FOA N/A
  • Fundamental
  • Price
  • AQST $4.07
  • FOA $23.13
  • Analyst Decision
  • AQST Strong Buy
  • FOA Buy
  • Analyst Count
  • AQST 7
  • FOA 2
  • Target Price
  • AQST $11.29
  • FOA $26.25
  • AVG Volume (30 Days)
  • AQST 1.3M
  • FOA 103.3K
  • Earning Date
  • AQST 08-05-2025
  • FOA 08-05-2025
  • Dividend Yield
  • AQST N/A
  • FOA N/A
  • EPS Growth
  • AQST N/A
  • FOA N/A
  • EPS
  • AQST N/A
  • FOA 3.94
  • Revenue
  • AQST $54,228,000.00
  • FOA $429,184,000.00
  • Revenue This Year
  • AQST N/A
  • FOA $21.89
  • Revenue Next Year
  • AQST $45.71
  • FOA $8.91
  • P/E Ratio
  • AQST N/A
  • FOA $5.86
  • Revenue Growth
  • AQST 5.29
  • FOA 155.35
  • 52 Week Low
  • AQST $2.12
  • FOA $5.14
  • 52 Week High
  • AQST $5.80
  • FOA $32.40
  • Technical
  • Relative Strength Index (RSI)
  • AQST 72.86
  • FOA 60.25
  • Support Level
  • AQST $3.62
  • FOA $22.77
  • Resistance Level
  • AQST $3.80
  • FOA $24.03
  • Average True Range (ATR)
  • AQST 0.19
  • FOA 0.78
  • MACD
  • AQST 0.05
  • FOA 0.09
  • Stochastic Oscillator
  • AQST 95.43
  • FOA 90.26

About AQST Aquestive Therapeutics Inc.

Aquestive Therapeutics Inc is a specialty pharmaceutical company engaged in developing and commercializing differentiated products to meet medical needs. Its later-stage product pipeline focuses on the treatment of diseases of the Central Nervous System (CNS), and an earlier-stage pipeline for the treatment of severe allergic reactions, including anaphylaxis. Its commercial product portfolio includes Suboxone, Emylif, Ondif and Sympazan. The product pipeline includes Libervant Buccal Film, AQST-108. The majority of its revenue comes from the United States.

About FOA Finance of America Companies Inc.

Finance of America Companies Inc is a financial services holding company that, through its operating subsidiaries, is a modern retirement solutions platform that provides customers with access to a range of retirement offerings centered on the home. In addition, FoA offers capital markets and portfolio management capabilities to optimize the distribution of its originated loans to investors. It operates through two segments: Retirement Solutions and Portfolio Management. It generates the majority of its revenue from Retirement Solutions.

Share on Social Networks: